In conjunction with lifestyle management, once-weekly semaglutide helped people with obesity lose a significant amount of weight, the Semaglutide Treatment Effect in People with Obesity (STEP) 1 ...

Semaglutide is a glucagon-like peptide-1 (GLP-1) analogue that is approved, at doses up to 1 mg administered subcutaneously once weekly, for the treatment of type 2 diabetes in adults and for ...

To take semaglutide, you’ll need a prescription from a doctor, like your primary care physician or endocrinologist. Share on Pinterest Shutterstock In 2017, the Food and Drug Administration (FDA ...

Semaglutide drugs, used to treat type 2 diabetes, also help with weight management. One such drug, sold under the brand name Wegovy, is approved as a treatment for overweight and obesity.

A study found that a 2.4-milligram weekly dose of semaglutide, sold as Wegovy for weight loss, led to an improvement of 17 points on a 100-point scale that’s used to assess symptoms of a ...

Semaglutide, a glucagon-like peptide-1 receptor agonist, has been shown to reduce the risk of adverse cardiovascular events in patients with diabetes. Whether semaglutide can reduce cardiovascular ...

People taking semaglutide, the popular medication for diabetes and weight loss, are more likely to report having thoughts of suicide compared with those taking other drugs, according to a new ...

The new class of weight-loss drugs known as GLP-1s can help reduce a type of heart failure, new research shows, in addition to other heart problems.

Tirzepatide and semaglutide are type 2 diabetes drugs often used for weight loss. While tirzepatide may potentially be more effective, it's too early to know that based on current research.

More information: Melissa-Rosina Pasqua et al, Subcutaneous weekly semaglutide with automated insulin delivery in type 1 diabetes: a double-blind, randomized, crossover trial, Nature Medicine ...